Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer : results of a phase I study

This phase I study was designed to determine the optimal dosages of a novel repetitive high-dose therapy regimen for patients with metastatic breast cancer (MBC). The planned treatment was three cycles of high-dose cyclophosphamide, thiotepa and docetaxel delivered every 35 days with progressive dos...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bone marrow transplantation (Basingstoke) 2000-11, Vol.26 (9), p.955-961
Hauptverfasser: PRINCE, H. M, RISCHIN, D, JUNEJA, S, WOLF, M, JANUSZEWICZ, E. H, RICHARDSON, G, SCARLETT, J, BRIGGS, P, TONER, G. C, SEYMOUR, J. F, BLAKEY, D, GATES, P, EERHARD, S, CHAPPLE, P, QUINN, M, BRETTELL, M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!